Hard to Treat Diseases (HTDS)

[abracky]

By: salvarai
28 Nov 2004, 04:55 PM EST
Msg. 2970 of 2971
Jump to msg. #
I am not sure the market has realized the importance of the dismissed case in Oklahoma. Basically, Shinn and Knight have NO case pending in any court at the moment against HTDS/HTTD. The injunction pending is against Shinn for criminal actions, and the Federal case in January is again against Shinn and seeks to confirm that all rights to Tubercin, except in Korea, are solely HTDS's property. As stated in the last news release, Shinn has filed claims against HTTD, but HTTD filed a motion to dismiss the claims. Based on the Oklaoma dismissal, strong chances are that Shinn's claims will again be dismissed. We are patiently awaiting the court's decision anytime now.

In my opinion, there is a strong possibility that SHinn will be denied any right to shares from the agreement, as his criminal actions simply cannot be rewarded by the court.

Now with HTTD's case recognition by the court imminent, and positive clinical results to be released in two weeks time at most, we are looking at extremely exciting times for shareholders.